Nordic Walking on Knee Osteoarthritis
Effects of Covid-19 and Nordic Walking on Older People with Knee Osteoarthritis
1 other identifier
interventional
71
1 country
1
Brief Summary
The goal of this randomized clinical trial is to improve osteoarthritis symptoms and quality of life in older people with knee osteoarthritis from a primary care center. The main question it aims to answer is:
- To participate in a Nordic walking reduces pain measured on WOMAC pain dimension?
- To participate in a Nordic walking improves mobility measured on WOMAC physical activitiy dimension? Researchers will compare pain and physical activity outcomes between intervention and control arm (randomly allocated).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedFirst Submitted
Initial submission to the registry
November 8, 2024
CompletedFirst Posted
Study publicly available on registry
November 12, 2024
CompletedNovember 12, 2024
November 1, 2024
1.4 years
November 8, 2024
November 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Western Ontario and McMaster Universities Osteoarthritis Index
The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is widely used in the evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items divided into 3 subscales: pain (5 items), stiffness (2 items) and physical function. WOMAC is available and validated in Spanish language. Overall, the sum of the three dimensions can have a minimum of zero points and a maximum of 96 points where 0 represents the best health status and 96 the worst possible status. The higher the score, the poorer the function.
From enrollment to the end of treatment at 10 weeks
Secondary Outcomes (1)
36-Item Short Form Survey Instrument (SF-36)
From enrollment to the end of treatment at 10 weeks
Other Outcomes (3)
Time up and go
From enrollment to the end of treatment at 10 weeks
Sit to stand
From enrollment to the end of treatment at 10 weeks
6-minute walk test
From enrollment to the end of treatment at 10 weeks
Study Arms (2)
Nordic walking program
ACTIVE COMPARATORPatients randomly allocated this arm participated in a nordic walking program to improve their pain symptoms and quality of life
Control group
PLACEBO COMPARATORPatients randomly assigned to this group received only one educational session to advice the convenience of exercising on their own initiative.
Interventions
The intervention is a defined program of Nordic walking and strengthening exercises for 10 weeks in a regimen of two days per week (two 75-minute sessions per week). In these sessions, they did Nordic walking three 5-minute breaks, where strength and proprioception exercises of the lower extremities were performed.
Patients in the control arm participated in a single session to advise them on the need for self-exercise.
Eligibility Criteria
You may qualify if:
- Aged of 60 years or older
- Knee osteoarthritis
- Body mass index less than 35 kg/m2
You may not qualify if:
- People who had a knee prostheses
- To have any contraindication for physical activity
- To have an acute exacerbation of any chronic condition at enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health and Welfare Sciences School
Vic, Barcelona, 08500, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pere Roura-Poch, PhD
Vic Hospital Consortium
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Philosophy doctor
Study Record Dates
First Submitted
November 8, 2024
First Posted
November 12, 2024
Study Start
February 1, 2020
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
November 12, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- 5 years after completion
- Access Criteria
- Adressing a letter with objectives and a justification about data needed
The principal investigator will provide participant data if a justified request is received.